What We Know From 4-Plus Years of Drug Patent Challenges Heard by the PTAB

This article was originally published at https://www.drugpatentwatch.com/blog/what-we-know-from-4-plus-years-of-drug-patent-challenges-heard-by-the-ptab/

While the Patent Trial and Appeal Board invalidates Orange Book-listed patents less than 20 percent of the time, it accepts 66 percent of petitions from generic drugmakers and takes no…

The post What We Know From 4-Plus Years of Drug Patent Challenges Heard by the PTAB appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog